Bak apoptotic pores involve a flexible C-terminal region and juxtaposition of the C-terminal transmembrane domains

Cell Death and Differentiation

Volumn 22, Issue 10, 2015, Pages 1665-1675

  Iyer, S ^a,b   Bell, F ^a   Westphal, D ^a,b   Anwari, K ^a,b   Gulbis, J ^a,b   Smith, B J ^c   Dewson, G ^a,b   Kluck, R M ^a,b  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c LA TROBE UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; DIMER; OLIGOMER; PROTEIN BAK; PROTEIN BAX;

APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHANNEL GATING; CONTROLLED STUDY; DIMERIZATION; HYDROPHILICITY; MEMBRANE BIOLOGY; MEMBRANE STRUCTURE; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; MUTAGENESIS; OUTER MEMBRANE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; SURFACE PROPERTY; ANIMAL; CHEMISTRY; HUMAN; METABOLISM; MOUSE; PHYSIOLOGY; PROTEIN MOTIF; PROTEIN MULTIMERIZATION;

AMINO ACID MOTIFS; ANIMALS; APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; HUMANS; MICE; MITOCHONDRIAL MEMBRANES; PROTEIN MULTIMERIZATION;

EID: 84941191862     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2015.15     Document Type: Article

References (72)

1. Bender T, Martinou JC. Where killers meet-permeabilization of the outer mitochondrial membrane during apoptosis. Cold Spring Harb Perspect Biol 2013; 5: a011106.
2. Tait SW, Green DR. Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 2010; 11: 621-632.
3. Westphal D, Dewson G, Czabotar PE, Kluck RM. Molecular biology of Bax and Bak activation and action. Biochim Biophys Acta 2011; 1813: 521-531.
4. Moldoveanu T, Liu Q, Tocilj A, Watson MH, Shore G, Gehring K. The x-ray structure of a BAK homodimer reveals an inhibitory zinc binding site. Mol Cell 2006; 24: 677-688.
5. Suzuki M, Youle RJ, Tjandra N. Structure of Bax: coregulation of dimer formation and intracellular localization. Cell 2000; 103: 645-654.
6. Brouwer JM, Westphal D, Dewson G, Robin AY, Uren RT, Bartolo R et al. Bak core and latch domains separate during activation, and freed core domains form symmetric homodimers. Mol Cell 2014; 55: 938-946.
7. Czabotar PE, Westphal D, Dewson G, Ma S, Hockings C, Fairlie WD et al. Bax crystal structures reveal how BH3 domains activate bax and nucleate its oligomerization to induce apoptosis. Cell 2013; 152: 519-531.
8. Dai H, Smith A, Meng XW, Schneider PA, Pang YP, Kaufmann SH. Transient binding of an activator BH3 domain to the Bak BH3-binding groove initiates Bak oligomerization. J Cell Biol 2011; 194: 39-48.
9. Du H, Wolf J, Schafer B, Moldoveanu T, Chipuk JE, Kuwana T. BH3 domains other than Bim and Bid can directly activate Bax/Bak. J Biol Chem 2011; 286: 491-501.
10. Leshchiner ES, Braun CR, Bird GH, Walensky LD. Direct activation of full-length proapoptotic BAK. Proc Natl Acad Sci USA 2013; 110: E986-E995.
11. Letai A, Bassik MC, Walensky LD, Sorcinelli MD, Weiler S, Korsmeyer SJ. Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2002; 2: 183-192.
12. Moldoveanu T, Grace CR, Llambi F, Nourse A, Fitzgerald P, Gehring K et al. BID-induced structural changes in BAK promote apoptosis. Nat Struct Mol Biol 2013; 20: 589-597.
13. Gavathiotis E, Suzuki M, Davis ML, Pitter K, Bird GH, Katz SG et al. BAX activation is initiated at a novel interaction site. Nature 2008; 455: 1076-1081.
14. Dewson G, Kratina T, Sim HW, Puthalakath H, Adams JM, Colman PM et al. To trigger apoptosis Bak exposes its BH3 domain and homo-dimerizes via BH3:grooove interactions. Mol Cell 2008; 30: 369-380.
15. Griffiths GJ, Corfe BM, Savory P, Leech S, Esposti MD, Hickman JA et al. Cellular damage signals promote sequential changes at the N-terminus and BH-1 domain of the pro-apoptotic protein Bak. Oncogene 2001; 20: 7668-7676.
16. Hsu YT, Youle RJ. Nonionic detergents induce dimerization among members of the Bcl-2 family. J Biol Chem 1997; 272: 13829-13834.
17. Bleicken S, Classen M, Padmavathi PV, Ishikawa T, Zeth K, Steinhoff HJ et al. Molecular details of Bax activation, oligomerization, and membrane insertion. J Biol Chem 2010; 285: 6636-6647.
18. Dewson G, Ma S, Frederick P, Hockings C, Tan I, Kratina T et al. Bax dimerizes via a symmetric BH3:groove interface during apoptosis. Cell Death Differ 2012; 19: 661-670.
19. Chi X, Kale J, Leber B, Andrews DW. Regulating cell death at, on, and in membranes. Biochim Biophys Acta 2014; 1843: 2100-2113.
20. Annis MG, Soucie EL, Dlugosz PJ, Cruz-Aguado JA, Penn LZ, Leber B et al. Bax forms multispanning monomers that oligomerize to permeabilize membranes during apoptosis. EMBO J 2005; 24: 2096-2103.
21. Aluvila SM, Mandal T, Hustedt E, Fajer P, Choe JY, Oh KJ. Organization of the mitochondrial apoptotic BAK pore: oligomerization of the Bak homodimers. J Biol Chem 2014; 289: 2537-2551.
22. Oh KJ, Singh P, Lee K, Foss K, Lee S, Park M et al. Conformational changes in BAK, a pore-forming proapoptotic Bcl-2 family member, upon membrane insertion and direct evidence for the existence of BH3-BH3 contact interface in BAK homo-oligomers. J Biol Chem 2010; 285: 28924-28937.
23. Westphal D, Dewson G, Menard M, Frederick P, Iyer S, Bartolo R et al. Apoptotic pore formation is associated with in-plane insertion of Bak or Bax central helices into the mitochondrial outer membrane. Proc Natl Acad Sci USA 2014; 111: E4076-E4085.
24. Dewson G, Kratina T, Czabotar P, Day CL, Adams JM, Kluck RM. Bak activation for apoptosis involves oligomerization of dimers via their alpha6 helices. Mol Cell 2009; 36: 696-703.
25. Ma S, Hockings C, Anwari K, Kratina T, Fennell S, Lazarou M et al. Assembly of the Bak apoptotic pore: a critical role for the Bak protein alpha6 helix in the multimerization of homodimers during apoptosis. J Biol Chem 2013; 288: 26027-26038.
26. Bleicken S, Landeta O, Landajuela A, Basanez G, Garcia-Saez AJ. Proapoptotic Bax and Bak proteins form stable protein-permeable pores of tunable size. J Biol Chem 2013; 288: 33241-33252.
27. Korsmeyer SJ, Wei MC, Saito M, Weiler S, Oh KJ, Schlesinger PH. Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c. Cell Death Differ 2000; 7: 1166-1173.
28. Setoguchi K, Otera H, Mihara K. Cytosolic factor- and TOM-independent import of C-tail-anchored mitochondrial outer membrane proteins. EMBO J 2006; 25: 5635-5647.
29. Gahl RF, He Y, Yu S, Tjandra N. Conformational rearrangements in the pro-apoptotic protein, Bax, as it inserts into mitochondria: a cellular death switch. J Biol Chem 2014; 289: 32871-32882.
30. Edlich F, Banerjee S, Suzuki M, Cleland MM, Arnoult D, Wang C et al. Bcl-x(L) Retrotranslocates Bax from the mitochondria into the cytosol. Cell 2011; 145: 104-116.
31. Wolter KG, Hsu YT, Smith CL, Nechushtan A, Xi XG, Youle RJ. Movement of Bax from the cytosol to mitochondria during apoptosis. J Cell Biol 1997; 139: 1281-1292.
32. Nechushtan A, Smith CL, Hsu YT, Youle RJ. Conformation of the Bax C-terminus regulates subcellular location and cell death. EMBO J 1999; 18: 2330-2341.
33. Ferrer PE, Frederick P, Gulbis JM, Dewson G, Kluck RM. Translocation of a Bak C-terminus mutant from cytosol to mitochondria to mediate cytochrome C release: implications for Bak and Bax apoptotic function. PLoS One 2012; 7: e31510.
34. Schinzel A, Kaufmann T, Schuler M, Martinalbo J, Grubb D, Borner C. Conformational control of Bax localization and apoptotic activity by Pro168. J Cell Biol 2004; 164: 1021-1032.
35. Cheng EH, Sheiko TV, Fisher JK, Craigen WJ, Korsmeyer SJ. VDAC2 inhibits BAK activation and mitochondrial apoptosis. Science 2003; 301: 513-517.
36. Roy SS, Ehrlich AM, Craigen WJ, Hajnoczky G. VDAC2 is required for truncated BID-induced mitochondrial apoptosis by recruiting BAK to the mitochondria. EMBO Rep 2009; 10: 1341-1347.
37. Lazarou M, Stojanovski D, Frazier AE, Kotevski A, Dewson G, Craigen WJ et al. Inhibition of Bak activation by VDAC2 is dependent on the Bak transmembrane anchor. J Biol Chem 2010; 285: 36876-36883.
38. Ma SB, Nguyen TN, Tan I, Ninnis R, Iyer S, Stroud DA et al. Bax targets mitochondria by distinct mechanisms before or during apoptotic cell death: a requirement for VDAC2 or Bak for efficient Bax apoptotic function. Cell Death Differ 2014; 21: 1925-1935.
39. Todt F, Cakir Z, Reichenbach F, Emschermann F, Lauterwasser J, Kaiser A et al. Differential retrotranslocation of mitochondrial Bax and Bak. EMBO J 2015; 34: 67-80.
40. del Mar Martinez-Senac M, Corbalan-Garcia S, Gomez-Fernandez JC. Conformation of the C-terminal domain of the pro-apoptotic protein Bax and mutants and its interaction with membranes. Biochemistry 2001; 40: 9983-9992.
41. Martinez-Senac M, Corbalan-Garcia S, Gomez-Fernandez JC. The structure of the C-terminal domain of the pro-apoptotic protein Bak and its interaction with model membranes. Biophys J 2002; 82: 233-243.
42. Torrecillas A, Martinez-Senac MM, Goormaghtigh E, de Godos A, Corbalan-Garcia S, Gomez-Fernandez JC. Modulation of the membrane orientation and secondary structure of the C-terminal domains of Bak and Bcl-2 by lipids. Biochemistry 2005; 44: 10796-10809.
43. Tatulian SA, Garg P, Nemec KN, Chen B, Khaled AR. Molecular basis for membrane pore formation by Bax protein carboxyl terminus. Biochemistry 2012; 51: 9406-9419.
44. Ausili A, Torrecillas A, Martinez-Senac MM, Corbalan-Garcia S, Gomez-Fernandez JC. The interaction of the Bax C-terminal domain with negatively charged lipids modifies the secondary structure and changes its way of insertion into membranes. J Struct Biol 2008; 164: 146-152.
45. Ausili A, de Godos A, Torrecillas A, Corbalan-Garcia S, Gomez-Fernandez JC. The interaction of the Bax C-terminal domain with membranes is influenced by the presence of negatively charged phospholipids. Biochim Biophys Acta 2009; 1788: 1924-1932.
46. Torrecillas A, Martinez-Senac MM, Ausili A, Corbalan-Garcia S, Gomez-Fernandez JC. Interaction of the C-terminal domain of Bcl-2 family proteins with model membranes. Biochim Biophys Acta 2007; 1768: 2931-2939.
47. Garg P, Nemec KN, Khaled AR, Tatulian SA. Transmembrane pore formation by the carboxyl terminus of Bax protein. Biochim Biophys Acta 2013; 1828: 732-742.
48. Goping IS, Gross A, Lavoie JN, Nguyen M, Jemmerson R, Roth K et al. Regulated targeting of BAX to mitochondria. J Cell Biol 1998; 143: 207-215.
49. Tran VH, Bartolo R, Westphal D, Alsop A, Dewson G, Kluck RM. Bak apoptotic function is not directly regulated by phosphorylation. Cell Death Dis 2013; 4: e452.
50. Kim PK, Annis MG, Dlugosz PJ, Leber B, Andrews DW. During apoptosis bcl-2 changes membrane topology at both the endoplasmic reticulum and mitochondria. Mol Cell 2004; 14: 523-529.
51. Colombini M, Mannella CA. VDAC, the early days. Biochim Biophys Acta 2012; 1818: 1438-1443.
52. Bass RB, Butler SL, Chervitz SA, Gloor SL, Falke JJ. Use of site-directed cysteine and disulfide chemistry to probe protein structure and dynamics: applications to soluble and transmembrane receptors of bacterial chemotaxis. Methods Enzymol 2007; 423: 25-51.
53. Fletcher JI, Meusburger S, Hawkins CJ, Riglar DT, Lee EF, Fairlie WD et al. Apoptosis is triggered when prosurvival Bcl-2 proteins cannot restrain Bax. Proc Natl Acad Sci USA 2008; 105: 18081-18087.
54. Wattenberg. An artificial mtochondrial tail signal/anchor sequence confirms a requirement for moderate hydrophobicity for targeting. Biosci Rep 2007; 27: 385-401.
55. L, but not Bcl-2, to the mitochondrial outer membrane. J Cell Biol2003; 160:53-64.
56. Lemmon MA, Flanagan JM, Hunt JF, Adair BD, Bormann BJ, Dempsey CE et al. Glycophorin A dimerization is driven by specific interactions between transmembrane alpha-helices. J Biol Chem 1992; 267: 7683-7689.
57. Sulistijo ES, Mackenzie KR. Structural basis for dimerization of the BNIP3 transmembrane domain. Biochemistry 2009; 48: 5106-5120.
58. Boohaker RJ, Zhang G, Lee MW, Nemec KN, Santra S, Perez JM et al. Rational development of a cytotoxic peptide to trigger cell death. Mol Pharm 2012; 9: 2080-2093.
59. Ma J, Yoshimura M, Yamashita E, Nakagawa A, Ito A, Tsukihara T. Structure of rat monoamine oxidase A and its specific recognitions for substrates and inhibitors. J Mol Biol 2004; 338: 103-114.
60. Mineev KS, Bocharov EV, Volynsky PE, Goncharuk MV, Tkach EN, Ermolyuk YS et al. Dimeric structure of the transmembrane domain of glycophorin a in lipidic and detergent environments. Acta Naturae 2011; 3: 90-98.
61. Suzuki M, Jeong SY, Karbowski M, Youle RJ, Tjandra N. The solution structure of human mitochondria fission protein Fis1 reveals a novel TPR-like helix bundle. J Mol Biol 2003; 334: 445-458.
62. Bocquet N, Nury H, Baaden M, Le Poupon C, Changeux JP, Delarue M et al. X-ray structure of a pentameric ligand-gated ion channel in an apparently open conformation. Nature 2009; 457: 111-114.
63. Mueller M, Grauschopf U, Maier T, Glockshuber R, Ban N. The structure of a cytolytic alpha-helical toxin pore reveals its assembly mechanism. Nature 2009; 459: 726-730.
64. Lee MT, Sun TL, Hung WC, Huang HW. Process of inducing pores in membranes by melittin. Proc Natl Acad Sci USA 2013; 110: 14243-14248.
65. Valero JG, Cornut-Thibaut A, Juge R, Debaud AL, Gimenez D, Gillet G et al. micro-Calpain conversion of antiapoptotic Bfl-1 (BCL2A1) into a prodeath factor reveals two distinct alpha-helices inducing mitochondria-mediated apoptosis. PLoS One 2012; 7: e38620.
66. Valero JG, Sancey L, Kucharczak J, Guillemin Y, Gimenez D, Prudent J et al. Bax-derived membrane-active peptides act as potent and direct inducers of apoptosis in cancer cells. J Cell Sci 2011; 124: 556-564.
67. Bleicken S, Jeschke G, Stegmueller C, Salvador-Gallego R, Garcia-Saez AJ, Bordignon E. Structural model of active bax at the membrane. Mol Cell 2014; 56: 496-505.
68. Careaga CL, Falke JJ. Thermal motions of surface alpha-helices in the D-galactose chemosensory receptor. Detection by disulfide trapping. J Mol Biol 1992; 226: 1219-1235.
69. Cole C, Barber JD, Barton GJ. The Jpred 3 secondary structure prediction server. Nucleic Acids Res 2008; 36: W197-W201.
70. Tripos Inc. SYBYL-X 1.2, Tripos International, St. Louis, MO, USA. 2005. http://www.certara.com.
71. Grundling A, Blasi U, Young R. Biochemical and genetic evidence for three transmembrane domains in the class I holin, lambda S. J Biol Chem 2000; 275: 769-776.
72. Riek RP, Rigoutsos I, Novotny J, Graham RM. Non-alpha-helical elements modulate polytopic membrane protein architecture. J Mol Biol 2001; 306: 349-362.